For the study, researchers examined clinical data on 100,848 metastatic lung, colorectal, breast and pancreatic cancer patients from the National Cancer Data Base. Patients all died within one month of being diagnosed between 2004 and 2014.
They found treatments varied based on cancer type, age, insurance and type of healthcare facility. However, many patients still sought aggressive treatments despite the advanced stage of their cancers. About 28 percent of colorectal cancer patients underwent surgery, and 18.7 percent of lung cancer patients had radiation.
The researchers concluded more research is needed to better identify cancer patients who will not benefit from these types of aggressive and expensive treatments.
More articles on clinical leadership & infection control:
Report: Veteran’s leg amputated after VA fails to log home care appointments
ICU healthcare workers have low hand hygiene compliance, study finds
Duodenoscope contamination rates higher than expected, says FDA
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
